EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clostridioides difficile Infection in Tuberculosis Patients: An Underrecognized Complication of Antituberculous Therapy

Jovan Javorac, Ana Milenković, Dragica Kovačević, Emilija Vujičić, Dejan Živanović

Journal of the Oman Medical Association · 03.07.2026 · 3 (2) · 11

DOI: 10.3390/joma3020011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Oman Medical Association, online erschienen am 03.07.2026. Verfasst von Jovan Javorac und 4 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) is the leading cause of antibiotic-associated diarrhea; however, its association with antituberculous therapy (ATT) remains underrecognized. This review examines the risk, mechanisms, and clinical implications of CDI in patients with active tuberculosis (TB). Although ATT is traditionally considered low risk, prolonged exposure, particularly to rifampicin, may lead to cumulative disruption of gut microbiota and loss of colonization resistance. A characteristic feature of CDI in this setting is delayed onset, typically occurring several weeks to months after ATT initiation, which complicates timely diagnosis. Rifampicin plays a dual role, contributing to microbiota alterations and selection of resistant strains, while potentially affecting the pharmacokinetics of co-administered drugs. CDI in TB patients is associated with increased morbidity and mortality, with reported mortality rates up to 9.9%. Fidaxomicin is preferred due to its microbiota-sparing effect and lower recurrence rates, although cost remains a major limitation in high TB-burden settings, since vancomycin is an appropriate alternative. Management requires an individualized approach that balances the risk of CDI recurrence against the necessity of maintaining effective TB therapy.

Zitieren

APA

Javorac, J., Milenković, A., Kovačević, D., Vujičić, E., & Živanović, D. (2026). Clostridioides difficile Infection in Tuberculosis Patients: An Underrecognized Complication of Antituberculous Therapy. Journal of the Oman Medical Association, 3(2), 11. https://doi.org/10.3390/joma3020011

Vancouver

Javorac J, Milenković A, Kovačević D, Vujičić E, Živanović D. Clostridioides difficile Infection in Tuberculosis Patients: An Underrecognized Complication of Antituberculous Therapy. Journal of the Oman Medical Association. 2026;3(2):11. doi:10.3390/joma3020011

BibTeX
@article{Javorac2026,
  author = {Javorac, Jovan and Milenković, Ana and Kovačević, Dragica and Vujičić, Emilija and Živanović, Dejan},
  title = {Clostridioides difficile Infection in Tuberculosis Patients: An Underrecognized Complication of Antituberculous Therapy},
  journal = {Journal of the Oman Medical Association},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {11},
  doi = {10.3390/joma3020011}
}
Kostenlos starten →